Talis Biomedical Corporation (TLIS) Financials

TLIS Assets vs Liabilities

DateAssetsLiabilities
June 30, 2024 72.7 million 24.1 million
March 31, 2024 82.5 million 25.8 million
Dec. 31, 2023 98.3 million 29.2 million
Sept. 30, 2023 107.2 million 25.7 million

TLIS Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2024 -11.3 million 791000
March 31, 2024 -6.4 million 601000
Dec. 31, 2023 -11.3 million 1.0 million
Sept. 30, 2023 -11.2 million 1.1 million

TLIS Net Income

No data available :(

TLIS Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2024 59.9 million 15.9 million 18.8 million
March 31, 2024 70.3 million 16.3 million 19.2 million
Dec. 31, 2023 76.7 million 16.8 million 19.7 million
Sept. 30, 2023 88.0 million 17.2 million 20.1 million

TLIS Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2024 1.8 million
March 31, 2024 1.8 million
Dec. 31, 2023 2.1 million
Sept. 30, 2023 1.8 million

TLIS Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2024 - 1.6 million 8.0 million -
March 31, 2024 - 2.5 million 6.4 million -
Dec. 31, 2023 93000 8.0 million 6.0 million -
Sept. 30, 2023 70000 8.3 million 8.8 million -

TLIS Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2024 - 84000
March 31, 2024 73000 268000
Dec. 31, 2023 151000 622000
Sept. 30, 2023 76000 6000

TLIS Revenue by Segment

Graph available only for paid members. Upgrade to see it.

TLIS

Price: $2.84

52 week price:
1.04
2.84

Earnings Per Share: -28.02 USD

P/E Ratio: -0.10

Exchange: OEM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 73600

Market Capitalization: 5.2 million

Links: